Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

August 10, 2020

Pfizer announces agreement with Gilead to manufacture Remdesivir to treat Covid-19

Pfizer announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for Covid-19.

Pfizer announces agreement with Gilead to manufacture Remdesivir to treat Covid-19